Home > Insider Trading > Filing (0001179110-21-000925)

Filing Details

Accession Number:: 0001179110-21-000925
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2021-01-28 21:53:07
Reporting Period:: 2021-01-26

Accepted Time:: 2021-01-28 21:53:07
Original Submission Date:: 2021-01-28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1727196	Scholar Rock Holding Corp	SRRK	Biological Products, (No Disgnostic Substances) (2836)	823750435

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1815432	John Gregory Carven	301 Binney Street Cambridge MA 02142	Head Of Research	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-01-26	2,543	$60.65	52,898	No	4	S	Direct
Common Stock	Disposition	2021-01-26	1,064	$61.52	51,834	No	4	S	Direct
Common Stock	Disposition	2021-01-27	5,400	$55.87	46,434	No	4	S	Direct
Common Stock	Disposition	2021-01-27	12,139	$56.72	34,295	No	4	S	Direct
Common Stock	Disposition	2021-01-27	1,561	$57.79	32,734	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

This transaction was effected pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.28 to $61.25. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The original Form 4, filed on January 28, 2021, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a sale that occurred on January 26, 2021, as a total of 8,417 shares sold when in fact 2,543 shares of the Issuer's common stock were sold. As a result of this administrative error, the number of shares sold by the reporting person following the corrected transaction reflects a decrease in the number of shares reported as sold by the reporting person by 5,874 shares.
The original Form 4, filed on January 28, 2021, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a sale that occurred on January 26, 2021, as a total of 8,417 shares sold when in fact 2,543 shares of the Issuer's common stock were sold. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects an increase in the number of shares reported as beneficially owned by the reporting person by 5,874 shares.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.35 to $61.89. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.35 to $61.89. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $56.31 to $57.17. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $57.39 to $58.28. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.